Contribution: Industrial Research Assistance Program – Contributions to Firms
NexPlasmaGen Incorporée
$119,200.00
Validation of a unique High Precision Cold Plasma Device as adjuvant for breast cancer radiotherapy Phase 2
FY 2019-20 · 2019-09-02
Summary
This project enhances the development of a unique high precision cold plasma device as a adjuvant for breast cancer radiotherapy. More particularly, the detailed design, fabrication and commissioning of this prototype will be performed so that it can be used in clinical trials in Canada.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Montreal|Montréal, Quebec, Canada
Recipient Type
For-profit organization
Business Number
819165614
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2019-09-02 | 2019-20 | $93,200.00 |
| 2 | 2019-09-02 | 2019-20 | $93,200.00 |
| 3 | 2019-09-02 | 2019-20 | $119,200.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 26,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 26 000 dollars.
Agreement End Date
2021-03-31
Agreement Number
935250
Agreement Start Date
2019-09-02
Agreement Title
Validation of a unique High Precision Cold Plasma Device as adjuvant for breast cancer radiotherapy Phase 2
Agreement Title (French)
Validation d'un dispositif unique de plasma froid de haute précision comme adjuvant pour la radiothérapie du cancer du sein - Phase 2
Agreement Type
Contribution
Agreement Value
$119,200.00
Amendment Date
2021-02-17
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project enhances the development of a unique high precision cold plasma device as a adjuvant for breast cancer radiotherapy. More particularly, the detailed design, fabrication and commissioning of this prototype will be performed so that it can be used in clinical trials in Canada.
Description (French)
Ce projet améliore le développement d'un dispositif unique de plasma froid de haute précision comme adjuvant pour la radiothérapie du cancer du sein. Plus particulièrement, la conception détaillée, la fabrication et la mise en service de ce prototype seront effectuées afin qu'il puisse être utilisé dans des essais cliniques au Canada.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Notre-Dame-de-Grâce--Westmount
Federal Riding (French)
Notre-Dame-de-Grâce--Westmount
Federal Riding Number
24053
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
819165614
Recipient City
Montreal|Montréal
Recipient Country
CA
Recipient Legal Name
NexPlasmaGen Incorporée
Recipient Postal Code
H4A 2T7
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2019-2020-Q3-935250
